Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02435667 · ClinicalTrials.gov registry record · NA

Resistance Training in HFpEF

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT02435667: Completed NA study, sponsored by Mayo Clinic.

NCT02435667 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02435667, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The objective of this proposal is to determine the effect of resistance exercise training on locomotor muscle function, exercise capacity, exertional symptoms, and quality of life in HF patients with preserved ejection fraction (HFpEF).

Primary Outcome

DEXA scan

Interventions

  • OTHER Quality of Life Questionnaire
  • OTHER Resistance Exercise Training
  • RADIATION DEXA bone scan
  • OTHER Cardiopulmonary Max Exercise Test
  • OTHER Submaximal Exercise Test

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2015-06
Est. Completion 2021-01
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT02435667 record still lists

NCT02435667 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 5 interventions - of which Quality of Life Questionnaire is the first listed.

NCT02435667 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02435667 about?

NCT02435667 is a clinical study titled "Resistance Training in HFpEF". The objective of this proposal is to determine the effect of resistance exercise training on locomotor muscle function, exercise capacity, exertional symptoms, and quality of life in HF patients with preserved ejection fraction (HFpEF).

What is the current status of trial NCT02435667?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-06. Estimated completion is 2021-01.

What interventions are being tested in trial NCT02435667?

The interventions under investigation include: Quality of Life Questionnaire (OTHER), Resistance Exercise Training (OTHER), DEXA bone scan (RADIATION), Cardiopulmonary Max Exercise Test (OTHER), Submaximal Exercise Test (OTHER).

Who is sponsoring clinical trial NCT02435667?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02435667's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02435667, the US trial registry maintained by the National Library of Medicine. NCT02435667 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.